# Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)

> **NCT03608397** · PHASE3 · COMPLETED · sponsor: **Revance Therapeutics, Inc.** · enrollment: 301 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** DaxibotulinumtoxinA for injection
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03608397
- **Lead sponsor:** Revance Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-20
- **Primary completion:** 2019-12-03
- **Final completion:** 2020-06-16
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2022-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03608397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03608397, "Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03608397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*